TALPHERA, INC. — Director's Dealing 2017

Sep 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2017-09-25

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-25	Common Stock	S	13827	—	Disposed	68504	Indirect

Footnotes

F1: 52,125 of the Shares are held in the Hamel Revocable Living Trust

F2: The Shares were sold in a range from $3.50-$4.50

F3: Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan